Increased bladder sensation and detrusor overactivity are the most frequent urodynamic findings of overactive bladder (OAB) in women with diabetes, researchers in Taiwan reported in Neurourology and Urodynamics (2009; published online ahead of print).
The Glucocard 01-mini Blood Glucose Monitoring System from Arkray USA, Inc., of Minneapolis, the only such system that features interchangeable faceplates so users can personalize the look of their monitor, has received marketing clearance.
Hemoglobin A1c (HbA1c) levels prior to radical prostatectomy (RP) may predict tumor aggressiveness in prostate cancer patients with diabetes, Korean researchers reported in The Prostate (2009; published online ahead of print).
Renal disease patients who have persistent proteinuria despite treatment with the highest approved dosage of the angiotensin receptor blocker candesartan may benefit from higher dosages, a Canadian study finds.
Nearly 25% of type 2 diabetic men in the Action for Health in Diabetes study reported having complete erectile dysfunction (ED), according to an article in The Journal of Sexual Medicine (2009; published online ahead of print).
Abbott Laboratories, in Abbott Park, Ill., has received approval of Trilipix (fenofibric acid) delayed-release capsules for use along with diet to help lower triglycerides and LDL and raise HDL in patients with lipid problems.
The FDA has announced new recommendations on evaluating cardiovascular (CV) risk of drugs intended to treat type 2 diabetes, asking manufacturers to provide evidence that the therapy will not increase the risk of heart attacks and other events.